U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07691125) titled 'Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome' on July 01.
Brief Summary: This is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which participants will receive rhGH injections. A safety follow-up period will then be conducted through Week 52.
Study Start Date: July 31, 2024
Study Type: INTERVENTIONAL
Condition:
Short Bowel Syndrome (SBS) in Adults
Intervention:
BIOLOGICAL: rhGH injection
rhGH ...